pRb is an obesity suppressor in hypothalamus and high-fat diet inhibits pRb in this location

Zhonglei Lu1, Genevieve Marcelin, Frederick Bauzon

  • 1Department of Developmental and Molecular Biology, Albert Einstein College of Medicine, Bronx, NY 10461, USA.

The EMBO Journal
|February 14, 2013
PubMed

Insights

The retinoblastoma protein (pRb) normally suppresses obesity in POMC neurons. High-fat diets and AMPK activation disrupt this by phosphorylating pRb, leading to obesity.

Area of Science:

  • Neuroscience
  • Metabolic Research
  • Cell Biology

Background:

  • The retinoblastoma protein (pRb) is a key tumor suppressor, regulating cell cycle progression.
  • The hypothalamus, particularly the arcuate nucleus (ARC), controls energy balance through distinct neuronal populations.
  • Obesity involves dysregulation of neuronal circuits that govern appetite and metabolism.

Purpose of the Study:

  • To investigate the role of pRb in the regulation of energy balance and obesity.
  • To determine if pRb functions within specific hypothalamic neuronal populations involved in appetite control.
  • To elucidate the molecular mechanisms by which diet and metabolic signals affect pRb activity in the ARC.

Main Methods:

  • Utilized a high-fat diet (HFD)-induced obesity mouse model.
  • Investigated pRb phosphorylation and E2F target gene expression in ARC neurons.
  • Employed genetic manipulation, including deletion of Rb1 in POMC and AGRP/NPY neurons, and E2f1 deletion.

Main Results:

  • HFD and AMPK activation induced pRb phosphorylation and E2F target gene de-repression in ARC neurons.
  • Deletion of Rb1 in POMC neurons led to cell-cycle re-entry, apoptosis, hyperphagia, obesity, and diabetes.
  • These obesity-related defects were ameliorated by combined deletion of E2f1, while Rb1 deletion in AGRP/NPY neurons had no effect.

Conclusions:

  • The pRb-E2F1 pathway acts as an obesity suppression mechanism within hypothalamic POMC neurons.
  • High-fat diet and AMPK signaling inhibit this protective mechanism via pRb phosphorylation in POMC neurons.
  • Targeting the pRb pathway in POMC neurons may offer therapeutic strategies for obesity.

Related Concept Videos

Regulation of Food Intake01:30

Regulation of Food Intake

Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Hormonal Regulation01:40

Hormonal Regulation

Hormones regulate a significant portion of digestion through activation of the neuroendocrine system. The neuroendocrine system of digestion contains many different hormones all with multiple functions that are both, directly and indirectly, involved in digestion.
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...